Title : Diabetes prevention: can insulin secretagogues do the job?

Pub. Date : 2011 Jul

PMID : 21185798






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The recent Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial reported that nateglinide, a non-sulfonylurea insulin secretagogue, failed to prevent progression from impaired glucose tolerance to diabetes. Valsartan insulin Homo sapiens